Featured in
Logo
Logo
Logo
Logo

Personalized Fertility & Gynaecology

Shazam, our proprietary AI engine assists the clinician to deliver superior outcomes. It considers biomarkers, gene expressions, growth factors, genetic factors, and comorbidities to personalize fertility and gynecology care.

personalize

Personalized dosage based on autologous plasma growth factors, and biomarkers to treat specific fertility and gynecology conditions.

Shazam is a full stack Reproductive Health Technologies Platform covers Embryo Grading, Hormonal Dosage, IVF Calendar, IVF Prediction Report, FET Calendar et al.

Seragen offers personalized immnunology therapies for complicated and unexplained infertility based on immuno assays, metablomics and epigenetics based markers.

Why Seragen?

01Driven by data

Speciality Fertility and Gynae Health Records and database built exclusively for reproductive disorders to advance data-driven, decision-making deliver superior clinical outcomes.

02Backed By Research

Our network of collaborators include fertility centers, gynecology clinics, academia, genome scholars, plasma and stem cell scientists who work to gather and analyze data, exchange expert perspectives, and search for discoveries to transform fertility and gynae care.

03Quality Care

All Seragen solutions are available at hospitals that uphold highest quality norms as prescribed by International Medical Council. Our point of care givers network adhere to stringent aseptic conditions adhering to NABH compliance and are ISO certified.

04Ready To Use

Our ready to use therapeutics is pre activated ensuring zero downtime to your caregiver, and our reports and protocols are real-time. Our mature fulfilment process ensures zero wait time and is in sync with the patient’s busy life.

conditions Treated

Point of Care Therapeutics

Our range of autologous fertility and gynecology therapeutic solutions

Our Network

Seragen solutions are available at our exclusive high quality nationwide network

Card image cap
Card image cap
Card image cap
Card image cap
Card image cap
Card image cap
My photo

Research

By integrating our work with academia and clinicians, we even deeper insights and accelerate possibilities in reproductive health.

Success Stories

Thickened

Affected by primary infertility, In Vitro Fertilization (IVF) was not successful as the endometrium was thin (never grew beyond 6mm). The pre-treatment thickness was 5.8mm

Joyous

Affected by primary infertility, and 3 implantation failures owing to thin endometrium (never grew beyond 6mm). The pre-treatment thickness was 5.8mm

Commendable

Affected by primary infertility, In Vitro Fertilization (IVF) was deemed ineffective as the endometrium was thin (never grew beyond 6mm). The pre-treatment thickness was 6.7mm

Transformed

Affected by primary infertility, In Vitro Fertilization (IVF) was unsuccessful as the endometrium was thin (never grew beyond 6mm), pre-treatment thickness was 6.7mm

Reversed

Affected by primary infertility, In Vitro Fertilization (IVF) was unsuccessful, because of problems caused by a thin endometrium (never grew beyond 7mm). The pre-treatment thickness was 7.1mm

Rescued

Affected by primary infertility, In Vitro Fertilization (IVF) was deemed ineffective, because of the problems caused by a thin endometrium (never grew beyond 7mm)

Clinician Manifesto